| 2938.90.00 | 00 | Other | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 50% |
| 2939.19.50 | 00 | Other | g | Free | | 10.6¡é/g |
| 2939.20.00 | 50 | Other | g | | | |
| 2939.49.01 | 00 | Other | kg | Free | | 15.4¡é/kg + 59% |
| 2939.59.00 | 00 | Other | kg | Free | | 25% |
| 2939.69.00 | 00 | Other | kg | Free | | 25% |
| 2939.99.00 | 00 | Other | kg | Free | | 25% |
| 2940.00.60 | 00 | Other | kg | 5.8% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 50% |
| 2941.10.50 | 00 | Other | kg | Free | | 15.4¡é/kg + 56.5% |
| 2941.20.50 | 00 | Other | g | Free | | 25% |
| 2941.90.10 | | Natural | | Free | | 10% |
| 2941.90.10 | 50 | Other | kg | | | |
| 2941.90.50 | 00 | Other | kg | Free | | 25% |
| 2942.00.03 | 00 | [2,2'-Thiobis(4-(1,1,3,3-tetramethyl-n-butyl)- phenolato)(2,1)]-O,O',S-(1-butanamine), nickel II | kg | Free | | 15.4¡é/kg + 46.5% |
| 2942.00.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 46.5% |
| 2942.00.35 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¡é/kg + 46.5% |
| 2942.00.50 | 00 | Other | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 3001.90.01 | | Other | kg | Free | | Free |
| 3001.90.01 | 10 | Liver | kg | | | |
| 3001.90.01 | 50 | Other | kg | | | |
| 3001.90.01 | 90 | Other | kg | | | |
| 3002.10.01 | 10 | Human blood plasma | kg | | | |
| 3002.10.01 | 20 | Normal human blood sera, whether or not freeze-dried | kg | | | |
| 3002.10.01 | 30 | Human immune blood sera | kg | | | |
| 3002.10.01 | 90 | Other | kg | | | |
